Lauren Hall Mccaslin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 S 52nd St, Rogers, AR 72758 Phone: 479-254-9662 Fax: 479-254-9652 |
Dr. William W Galloway, M.D. Dermatology - Procedural Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1602 W Main St, Russellville, AR 72801 Phone: 479-968-6969 Fax: 479-968-4290 |
Dr. William John Helms, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2210 W Main, Russellville, AR 72802 Phone: 479-968-8940 Fax: 479-968-8901 |
Bradley A White, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1903 E Beebe Capps Blvd, Searcy, AR 72143 Phone: 501-279-3838 Fax: 501-279-1212 |
Bertram David Kaplan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 S Rhodes St, Suite G, West Memphis, AR 72301 Phone: 870-735-6430 Fax: 870-735-6432 |
News Archive
Newly released findings of a multinational survey conducted on behalf of the International Osteoporosis Foundation (IOF) show clear disparities between patients' and doctors' perceptions of osteoporosis and its management.
A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue of Science Translational Medicine, a team of researchers from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard describe finding a population of HIV-specific CD4 T cells - cells traditionally thought to direct and support activities of other immune cells - that can directly kill HIV-infected cells.
Family Research Council President Tony Perkins responded today to the U.S. Senate's approval of an amendment authored by U.S. Sen. Barbara Mikulski (D-MD) to authorize the Health Resources and Services Administration (HRSA) to include abortion as "preventive care" in their guidelines.
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells. By decoding this genomic data and looking for deletions and mutations associated with cancer, the research team believes this discovery could be translated into a test that helps physicians detect cancer and treat patients.
› Verified 6 days ago